How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Exclusive: Campaign group calls on institutional shareholders to vote against re-election of bosses overseeing net zero row-back Bank chairs who water down their lenders’ climate commitments this year ...

The Trump administration in recent weeks has shifted its immigration enforcement rhetoric and tactics following the deaths of two U.S. citizens in Minnesota. Hundreds of Swiss bank accounts with ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Earlier in January, Recursion Pharmaceuticals updated investors at the JP Morgan Healthcare Conference on its AI-powered drug discovery platform, clinical programs, and collaborations with partners ...

The funding discussions highlight ongoing investor demand for new and unproven research labs looking to find novel approaches to AI that push the technology forward. Recursive’s goal is to develop ...

Canadian Prime Minister Mark Carney has refuted claims that he retracted his statements made at the World Economic Forum in Davos, Switzerland, during a recent conversation with President Donald Trump ...

Days after the brutal execution of 37-year-old Alex Pretti in Minneapolis, we still don’t know the identities of the masked ICE agents who shot him dead. They fled the scene and are nowhere to be ...

Java Development Kit (JDK) 26, a planned update to standard Java due March 17, 2026, has reached the initial release candidate (RC) stage. The RC is open for critical bug fixes, with the feature set ...